Cash flow Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 06:25:29 2025-06-19 am EDT			5-day change	1st Jan Change
486.35 ^DKK	+0.80%		-6.79%	-22.47%

Jun. 18	US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list	RE
Jun. 18	US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list	RE

72422aef7d3e8137702c53.FYrqS5apuRu8Y8Ks1oDecY5JAADSNVpdeAuoFy_Rims.eb2leuPDynPGMJqU4cmKFN5xS2_kWWJpEmaFI3_psz8g8IF7x4TeVI4B8g

Published financial data: NOVO NORDISK A/S

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	127B	141B	177B	232B	290B
Total Revenues	127B	141B	177B	232B	290B
Cost of Goods Sold, Total	20.93B	23.66B	28.45B	35.76B	43.56B
Gross Profit	106B	117B	149B	196B	247B
Selling General & Admin Expenses, Total	36.89B	41.06B	50.68B	61.6B	67.37B
R&D Expenses	15.11B	17.2B	23.29B	31.03B	40.07B
Other Operating Expenses	-460M	-456M	-1.08B	-119M	-476M
Other Operating Expenses, Total	51.54B	57.8B	72.89B	92.51B	107B
Operating Income	54.48B	59.34B	75.62B	104B	140B
Interest Expense, Total	-390M	-289M	-378M	-542M	-1.64B
Interest And Investment Income	337M	231M	239M	1.07B	1.84B
Net Interest Expenses	-53M	-58M	-139M	527M	198M
Income (Loss) On Equity Invest.	149M	-24M	-189M	81M	-17M
Currency Exchange Gains (Loss)	-747M	344M	-4.65B	1.65B	-1.02B
Other Non Operating Income (Expenses)	-150M	-122M	-181M	-197M	-289M
EBT, Excl. Unusual Items	53.68B	59.48B	70.46B	106B	139B
Merger & Related Restructuring Charges	-	-124M	-51M	-	-978M
Gain (Loss) On Sale Of Investments	-195M	296M	-587M	37M	-17M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-350M	-573M	-760M	-1.41B	-10.56B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	53.13B	59.08B	69.06B	105B	127B
Income Tax Expense	10.99B	11.32B	13.54B	20.99B	26.2B
Earnings From Continuing Operations	42.14B	47.76B	55.52B	83.68B	101B
Net Income to Company	42.14B	47.76B	55.52B	83.68B	101B
Net Income - (IS)	42.14B	47.76B	55.52B	83.68B	101B
Net Income to Common Incl Extra Items	42.14B	47.76B	55.52B	83.68B	101B
Net Income to Common Excl. Extra Items	42.14B	47.76B	55.52B	83.68B	101B
Per Share Items
Net EPS - Basic	9.03	10.4	12.26	18.67	22.67
Basic EPS - Continuing Operations	9.03	10.4	12.26	18.67	22.67
Basic Weighted Average Shares Outstanding	4.67B	4.59B	4.53B	4.48B	4.45B
Net EPS - Diluted	9	10.37	12.22	18.62	22.63
Diluted EPS - Continuing Operations	9	10.37	12.22	18.62	22.63
Diluted Weighted Average Shares Outstanding	4.68B	4.61B	4.54B	4.49B	4.46B
Normalized Basic EPS	7.19	8.09	9.72	14.79	19.47
Normalized Diluted EPS	7.17	8.07	9.69	14.75	19.43
Dividend Per Share	4.55	5.2	6.2	9.4	11.4
Payout Ratio	47.75	45.06	45.57	37.96	43.71
American Depositary Receipts Ratio (ADR)	0	0	0	0	0
Supplemental Items
EBITDA	58.79B	63.55B	80.93B	110B	147B
EBITA	55.57B	60.21B	77.02B	106B	142B
EBIT	54.48B	59.34B	75.62B	104B	140B
EBITDAR	59.1B	64.86B	82.42B	112B	-
Effective Tax Rate - (Ratio)	20.69	19.17	19.6	20.05	20.6
Total Current Taxes	10.99B	13.27B	18.17B	25B	32.25B
Total Deferred Taxes	-2M	-1.94B	-4.63B	-4.01B	-6.05B
Normalized Net Income	33.55B	37.18B	44.04B	66.28B	86.72B
Interest on Long-Term Debt	97M	-	-	-	-
Non-Cash Pension Expense	138M	139M	185M	126M	156M
Supplemental Operating Expense Items
Selling and Marketing Expenses	32.93B	37.01B	46.22B	56.74B	62.09B
General and Administrative Expenses	3.96B	4.05B	4.47B	4.86B	5.28B
Research And Development Expense From Footnotes	15.46B	17.77B	24.05B	32.44B	48.06B
Net Rental Expense, Total	312M	1.3B	1.49B	1.83B	-
Imputed Operating Lease Interest Expense	131M	163M	172M	301M	-
Imputed Operating Lease Depreciation	181M	1.14B	1.32B	1.53B	-
Stock-Based Comp., Other (Total)	823M	1.04B	1.54B	2.15B	2.29B
Total Stock-Based Compensation	823M	1.04B	1.54B	2.15B	2.29B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	12.76B	10.72B	12.65B	14.39B	15.66B
Short Term Investments	-	6.76B	10.92B	15.84B	10.65B
Total Cash And Short Term Investments	12.76B	17.48B	23.57B	30.23B	26.31B
Accounts Receivable, Total	27.73B	40.64B	50.56B	64.77B	71.95B
Other Receivables	4.45B	6.16B	6.94B	10.49B	15.46B
Total Receivables	32.18B	46.8B	57.5B	75.26B	87.41B
Inventory	18.54B	19.62B	24.39B	31.81B	40.85B
Other Current Assets, Total	2.33B	1.69B	2.73B	2.34B	6.33B
Total Current Assets	65.81B	85.6B	108B	140B	161B
Gross Property Plant And Equipment	86.69B	95.89B	111B	139B	215B
Accumulated Depreciation	-36.42B	-40.52B	-44.76B	-47.62B	-52.4B
Net Property Plant And Equipment	50.27B	55.36B	66.67B	90.96B	162B
Long-term Investments	1.65B	1.44B	1.34B	1.66B	2.68B
Goodwill	-	4.35B	5.09B	4.46B	20.06B
Other Intangibles, Total	20.66B	38.82B	46.32B	55.94B	91.03B
Deferred Tax Assets Long-Term	5.86B	8.67B	13.43B	20.38B	24.63B
Other Long-Term Assets, Total	674M	267M	206M	1.43B	4.02B
Total Assets	145B	195B	241B	314B	466B
Liabilities
Accounts Payable, Total	5.72B	8.87B	15.59B	25.61B	28.85B
Accrued Expenses, Total	33.75B	50.57B	69.18B	100B	119B
Short-term Borrowings	6.68B	12.86B	480M	456M	5.79B
Current Portion of Long-Term Debt	-	-	-	4.85B	5.98B
Current Portion of Leases	775M	822M	986M	1.17B	1.34B
Current Income Taxes Payable	3.91B	3.66B	7.09B	7.12B	9.72B
Other Current Liabilities	19.43B	22.74B	27.62B	30.43B	46.92B
Total Current Liabilities	70.27B	99.52B	121B	170B	218B
Long-Term Debt	-	9.65B	20.78B	15.98B	84.25B
Long-Term Leases	2.9B	3.31B	3.54B	4.55B	5.43B
Pension & Other Post Retirement Benefits	1.4B	1.28B	762M	742M	903M
Deferred Tax Liability Non Current	2.5B	5.27B	7.06B	10.16B	5.43B
Other Non Current Liabilities	4.53B	4.73B	4.69B	6.84B	8.78B
Total Liabilities	81.6B	124B	158B	208B	322B
Common Stock, Total	470M	462M	456M	451M	446M
Retained Earnings	63.77B	72B	80.59B	105B	144B
Treasury Stock	-8M	-6M	-6M	-5M	-2M
Comprehensive Income and Other	-911M	-1.71B	2.45B	1.28B	-1.41B
Total Common Equity	63.32B	70.75B	83.49B	107B	143B
Total Equity	63.32B	70.75B	83.49B	107B	143B
Total Liabilities And Equity	145B	195B	241B	314B	466B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.62B	4.56B	4.5B	4.46B	4.44B
ECS Total Common Shares Outstanding	4.62B	4.56B	4.5B	4.46B	4.44B
Book Value / Share	13.69	15.52	18.55	23.9	32.31
Tangible Book Value	42.67B	27.58B	32.07B	46.16B	32.4B
Tangible Book Value Per Share	9.23	6.05	7.13	10.35	7.29
Total Debt	10.36B	26.64B	25.78B	27.01B	103B
Net Debt	-2.4B	9.16B	2.21B	-3.22B	76.48B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.4B	-	-	-	-
Debt Equivalent Oper. Leases	2.5B	10.42B	11.93B	14.66B	-
Equity Method Investments, Total	582M	525M	327M	410M	400M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	3.33B	4.31B	6.39B	9.5B	13.37B
Inventories - Work In Process, Total	12.25B	12.28B	13.67B	17.6B	22.34B
Inventories - Finished Goods, Total	5.11B	5.28B	6.04B	7.22B	8.87B
Land - (BS)	37.51B	41.08B	43.4B	48.99B	62.14B
Machinery, Total	38.38B	43.72B	45.66B	49.93B	73.36B
Full Time Employees	44.72K	47.79K	54.39K	63.37K	76.3K
Part Time Employees	600	686	792	949	1.05K
Accumulated Allowance for Doubtful Accounts (Supple)	1.38B	1.43B	1.52B	1.79B	2.13B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	42.14B	47.76B	55.52B	83.68B	101B
Depreciation & Amortization - CF	4.18B	4.24B	4.95B	5.46B	6.03B
Amortization of Goodwill and Intangible Assets - (CF)	1.1B	866M	1.4B	1.62B	2.26B
Depreciation & Amortization, Total	5.28B	5.11B	6.36B	7.08B	8.29B
Amortization of Deferred Charges, Total - (CF)	-	200M	195M	213M	255M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	195M	-340M	124M	-	-5.08B
Asset Writedown & Restructuring Costs	477M	714M	809M	2.12B	10.56B
(Income) Loss On Equity Investments - (CF)	-149M	24M	189M	-	17M
Stock-Based Compensation (CF)	823M	1.04B	1.54B	-	2.29B
Other Operating Activities, Total	7.54B	9.15B	19.48B	28.06B	15.64B
Change In Accounts Receivable	-2.82B	-12.91B	-9.92B	-14.21B	-7.18B
Change In Inventories	-895M	-1.08B	-4.77B	-7.42B	-9.04B
Change In Accounts Payable	-641M	3.15B	6.72B	10.02B	3.24B
Change in Other Net Operating Assets	5M	2.18B	2.63B	-631M	982M
Cash from Operations	51.95B	55B	78.89B	109B	121B
Capital Expenditure	-5.82B	-6.34B	-12.15B	-25.81B	-47.16B
Sale of Property, Plant, and Equipment	7M	-	-	-	-
Cash Acquisitions	-	-18.28B	-7.08B	-	-82.16B
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-16.26B	-1.05B	-2.61B	-13.09B	-4.14B
Investment in Marketable and Equity Securities, Total	-380M	-5.94B	-3.09B	-5B	4.58B
Other Investing Activities, Total	18M	4M	-	-	-
Cash from Investing	-22.44B	-31.6B	-24.92B	-43.89B	-129B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	5.68B	22.16B	11.22B	-	79.39B
Total Debt Issued	5.68B	22.16B	11.22B	-	79.39B
Long-Term Debt Repaid, Total	-950M	-6.69B	-13.62B	-1.47B	-6.34B
Total Debt Repaid	-950M	-6.69B	-13.62B	-1.47B	-6.34B
Repurchase of Common Stock	-16.86B	-19.45B	-24.09B	-29.92B	-20.18B
Common Dividends Paid	-20.12B	-21.52B	-25.3B	-31.77B	-44.14B
Common & Preferred Stock Dividends Paid	-20.12B	-21.52B	-25.3B	-31.77B	-44.14B
Cash from Financing	-32.24B	-25.49B	-51.8B	-63.16B	8.74B
Foreign Exchange Rate Adjustments	-456M	591M	-238M	-119M	455M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-3.18B	-1.51B	1.93B	1.74B	1.26B
Supplemental Items
Cash Interest Paid	422M	261M	272M	491M	612M
Cash Income Tax Paid (Refund)	10.11B	14.44B	14.52B	25.9B	29.64B
Levered Free Cash Flow	17.06B	43.83B	57.5B	54.1B	61.99B
Unlevered Free Cash Flow	17.3B	44.01B	57.73B	54.44B	63.01B
Change In Net Working Capital	766M	-7.96B	-17.13B	-18.91B	-16.06B
Net Debt Issued / Repaid	4.73B	15.47B	-2.41B	-1.47B	73.06B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	25.17	21.85	21.69	23.39	22.41
Return on Total Capital	50.16	43.36	45.74	53.53	46.03
Return On Equity %	69.7	71.24	72	88.07	80.78
Return on Common Equity	69.7	71.24	72	88.07	80.78
Margin Analysis
Gross Profit Margin %	83.51	83.2	83.92	84.6	85
SG&A Margin	29.06	29.16	28.64	26.52	23.2
EBITDA Margin %	46.31	45.14	45.73	47.28	50.51
EBITA Margin %	43.78	42.76	43.53	45.47	48.94
EBIT Margin %	42.91	42.15	42.73	44.77	48.17
Income From Continuing Operations Margin %	33.19	33.92	31.38	36.03	34.78
Net Income Margin %	33.19	33.92	31.38	36.03	34.78
Net Avail. For Common Margin %	33.19	33.92	31.38	36.03	34.78
Normalized Net Income Margin	26.43	26.4	24.89	28.54	29.86
Levered Free Cash Flow Margin	13.44	31.13	32.49	23.29	21.35
Unlevered Free Cash Flow Margin	13.63	31.26	32.63	23.44	21.7
Asset Turnover
Asset Turnover	0.94	0.83	0.81	0.84	0.74
Fixed Assets Turnover	2.52	2.67	2.9	2.95	2.29
Receivables Turnover (Average Receivables)	4.82	4.12	3.88	4.03	4.25
Inventory Turnover (Average Inventory)	1.16	1.24	1.29	1.27	1.2
Short Term Liquidity
Current Ratio	0.94	0.86	0.89	0.82	0.74
Quick Ratio	0.64	0.65	0.67	0.62	0.52
Operating Cash Flow to Current Liabilities	0.74	0.55	0.65	0.64	0.56
Days Sales Outstanding (Average Receivables)	75.89	88.63	94.06	90.62	86.15
Days Outstanding Inventory (Average Inventory)	316.28	294.35	282.33	286.77	305.25
Average Days Payable Outstanding	101.24	107.59	134.38	174.07	189.45
Cash Conversion Cycle (Average Days)	290.93	275.38	242.01	203.32	201.96
Long Term Solvency
Total Debt/Equity	16.35	37.66	30.88	25.34	71.64
Total Debt / Total Capital	14.06	27.36	23.6	20.22	41.74
LT Debt/Equity	4.57	18.32	29.13	19.26	62.5
Long-Term Debt / Total Capital	3.93	13.31	22.25	15.37	36.41
Total Liabilities / Total Assets	56.3	63.63	65.4	66.12	69.2
EBIT / Interest Expense	139.68	205.33	200.05	191.86	85.29
EBITDA / Interest Expense	153.21	223.02	216.87	204.92	90.35
(EBITDA - Capex) / Interest Expense	138.27	201.1	184.74	157.3	61.59
Total Debt / EBITDA	0.17	0.41	0.31	0.24	0.69
Net Debt / EBITDA	-0.04	0.14	0.03	-0.03	0.52
Total Debt / (EBITDA - Capex)	0.19	0.46	0.37	0.32	1.02
Net Debt / (EBITDA - Capex)	-0.04	0.16	0.03	-0.04	0.76
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.04	10.91	25.68	31.26	25.03
Gross Profit, 1 Yr. Growth %	3.47	10.5	26.77	32.32	25.34
EBITDA, 1 Yr. Growth %	3.01	8.49	27.34	35.78	32.7
EBITA, 1 Yr. Growth %	3.01	8.75	27.93	37.2	33.69
EBIT, 1 Yr. Growth %	1.9	8.93	27.43	37.61	33.6
Earnings From Cont. Operations, 1 Yr. Growth %	8.18	13.33	16.27	50.71	20.68
Net Income, 1 Yr. Growth %	8.18	13.33	16.27	50.71	20.68
Normalized Net Income, 1 Yr. Growth %	8.05	10.82	18.46	50.62	29.96
Diluted EPS Before Extra, 1 Yr. Growth %	9.95	15.16	17.84	52.37	21.54
Accounts Receivable, 1 Yr. Growth %	11.33	46.55	24.4	28.11	11.08
Inventory, 1 Yr. Growth %	5.07	5.85	24.3	30.44	28.41
Net Property, Plant and Equip., 1 Yr. Growth %	-0.56	10.13	20.43	36.43	78.63
Total Assets, 1 Yr. Growth %	15.37	34.22	24.03	30.35	48.11
Tangible Book Value, 1 Yr. Growth %	-17.56	-35.37	16.3	41.81	-29.81
Common Equity, 1 Yr. Growth %	9.95	11.72	18.01	27.64	34.65
Cash From Operations, 1 Yr. Growth %	11.05	5.87	43.43	38.06	11.07
Capital Expenditures, 1 Yr. Growth %	-34.79	8.76	91.73	112.46	82.76
Levered Free Cash Flow, 1 Yr. Growth %	-37.24	157	31.17	-5.85	13.64
Unlevered Free Cash Flow, 1 Yr. Growth %	-36.66	154.42	31.17	-5.65	14.81
Dividend Per Share, 1 Yr. Growth %	8.98	14.29	19.23	51.61	21.28
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.54	7.42	18.06	28.44	28.11
Gross Profit, 2 Yr. CAGR %	6.08	7.2	18.36	29.52	28.91
EBITDA, 2 Yr. CAGR %	7.18	6.24	17.55	31.23	34.46
EBITA, 2 Yr. CAGR %	8.45	6.61	18.1	32.36	35.67
EBIT, 2 Yr. CAGR %	7.38	6.33	18.2	32.52	36.01
Earnings From Cont. Operations, 2 Yr. CAGR %	4.44	10.73	14.79	32.37	34.86
Net Income, 2 Yr. CAGR %	4.44	10.73	14.79	32.37	34.86
Normalized Net Income, 2 Yr. CAGR %	6.36	10.52	14.95	33.67	40.33
Diluted EPS Before Extra, 2 Yr. CAGR %	6.33	12.52	16.49	34	36.08
Accounts Receivable, 2 Yr. CAGR %	10.32	27.73	35.02	26.24	19.29
Inventory, 2 Yr. CAGR %	6.52	5.46	14.7	27.33	29.42
Net Property, Plant and Equip., 2 Yr. CAGR %	9.54	4.65	15.16	28.18	56.11
Total Assets, 2 Yr. CAGR %	14.38	24.44	29.02	27.15	38.95
Tangible Book Value, 2 Yr. CAGR %	-4.41	-27.01	-13.3	29.38	-0.23
Common Equity, 2 Yr. CAGR %	10.52	10.83	14.82	22.73	31.1
Cash From Operations, 2 Yr. CAGR %	7.91	8.43	23.23	40.72	23.83
Capital Expenditures, 2 Yr. CAGR %	-22.25	-15.78	44.4	101.83	97.06
Levered Free Cash Flow, 2 Yr. CAGR %	-21.24	27.93	84.1	11.02	3.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	-20.75	27.86	83.17	11.14	4.47
Dividend Per Share, 2 Yr. CAGR %	5.67	11.6	16.73	34.45	35.6
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.36	7.98	13.19	22.31	27.29
Gross Profit, 3 Yr. CAGR %	4.07	7.53	13.36	22.84	28.2
EBITDA, 3 Yr. CAGR %	4.08	7.49	12.85	23.31	32
EBITA, 3 Yr. CAGR %	4.31	8.41	13.29	24.13	33.1
EBIT, 3 Yr. CAGR %	3.62	7.89	12.95	24.32	33.18
Earnings From Cont. Operations, 3 Yr. CAGR %	3.39	7.33	12.54	25.7	28.35
Net Income, 3 Yr. CAGR %	3.39	7.33	12.54	25.7	28.35
Normalized Net Income, 3 Yr. CAGR %	3.29	7.82	13.1	25.76	32.71
Diluted EPS Before Extra, 3 Yr. CAGR %	5.38	9.19	14.27	27.4	29.71
Accounts Receivable, 3 Yr. CAGR %	11.21	21.28	26.61	32.67	20.97
Inventory, 3 Yr. CAGR %	6.44	6.3	11.4	19.73	27.69
Net Property, Plant and Equip., 3 Yr. CAGR %	12.56	9.74	9.67	21.86	43.18
Total Assets, 3 Yr. CAGR %	12.29	20.64	24.3	29.47	33.79
Tangible Book Value, 3 Yr. CAGR %	-2.82	-16.1	-14.75	2.65	5.52
Common Equity, 3 Yr. CAGR %	8.33	10.92	13.17	18.94	26.58
Cash From Operations, 3 Yr. CAGR %	8.06	7.22	19.03	27.98	30.05
Capital Expenditures, 3 Yr. CAGR %	-8.59	-13.05	10.79	64.24	95.26
Levered Free Cash Flow, 3 Yr. CAGR %	-7.24	16.82	29	47.2	12.19
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.88	16.91	28.96	46.8	12.65
Dividend Per Share, 3 Yr. CAGR %	5.05	8.47	14.09	27.36	29.91
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.3	4.72	9.64	15.74	18.94
Gross Profit, 5 Yr. CAGR %	2.93	4.37	9.56	15.84	19.35
EBITDA, 5 Yr. CAGR %	3.47	4.24	9.19	16.5	21.1
EBITA, 5 Yr. CAGR %	3.58	4.27	9.48	17.45	21.82
EBIT, 5 Yr. CAGR %	3.16	4.15	9.08	17.09	21.66
Earnings From Cont. Operations, 5 Yr. CAGR %	3.86	4.72	7.81	16.72	20.99
Net Income, 5 Yr. CAGR %	3.86	4.72	7.81	16.72	20.99
Normalized Net Income, 5 Yr. CAGR %	5.72	4.48	7.66	17.45	23.29
Diluted EPS Before Extra, 5 Yr. CAGR %	5.9	6.75	9.69	18.51	22.54
Accounts Receivable, 5 Yr. CAGR %	12.36	14.97	20.18	23.24	23.63
Inventory, 5 Yr. CAGR %	7.76	6.47	9.67	14.26	18.29
Net Property, Plant and Equip., 5 Yr. CAGR %	14.5	12.9	13.6	16.77	26.3
Total Assets, 5 Yr. CAGR %	9.56	14.8	18.71	23.21	29.97
Tangible Book Value, 5 Yr. CAGR %	-0.98	-8.31	-7.16	-0.23	-8.95
Common Equity, 5 Yr. CAGR %	6.16	9.34	10.88	15.5	20.03
Cash From Operations, 5 Yr. CAGR %	6.29	2.63	13.89	19.54	20.93
Capital Expenditures, 5 Yr. CAGR %	2.2	-2.17	9.76	21.78	39.49
Levered Free Cash Flow, 5 Yr. CAGR %	-9.84	8.96	21.89	14.5	18.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	-9.61	9.02	21.93	14.6	18.54
Dividend Per Share, 5 Yr. CAGR %	7.29	6.47	9.57	18.2	22.25